Latest News and Press Releases
Want to stay updated on the latest news?
-
Pressmeddelande 2 mars 2020 Immunicum AB (publ) meddelar att bolagets finanschef, Michaela Gertz, lämnar sin tjänst till sommaren 2020 Immunicum AB (publ) meddelar att bolagets finanschef...
-
Press Release 2 March 2020 Immunicum AB (publ) Announces that its CFO, Michaela Gertz, Will Leave the Company this Summer Immunicum AB (publ) announces that the company's CFO, Michaela Gertz,...
-
Pressmeddelande 18 februari 2020 Immunicum AB (publ) Bokslutskommuniké 2019 OKTOBER – DECEMBER I SAMMANDRAG Nettoomsättning för kvartalet uppgick till - KSEK (- KSEK).Kvartalets resultat uppgick...
-
Press Release 18 February 2020 Immunicum AB (publ) Year-End Report 2019 October – December in Summary Net sales for the period amounted to KSEK - (-).Result for the quarter amounted to KSEK...
-
Pressmeddelande 6 februari 2020 Immunicum AB (publ) meddelar uppdaterade data från MERECA-studien med ilixadencel i njurcancer vid ASCO-SITC Clinical Immuno-Oncology-symposiet -- Data från december...
-
Press Release 6 February 2020 Immunicum AB (publ) Presents Updated Data from Phase II MERECA Trial of Ilixadencel in Kidney Cancer at ASCO-SITC Clinical Immuno-Oncology Symposium --...
-
Pressmeddelande 3 februari 2020 Immunicum AB (publ) meddelar att abstrakten inför ASCO-SITC Clinical Immuno-Oncology Symposium publicerats Immunicum AB (publ; IMMU.ST) meddelade i dag att...
-
Press Release 3 February 2020 Immunicum AB (publ) Announces Publication of Abstracts for the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium Immunicum AB (publ; IMMU.ST) announced today the...
-
Pressmeddelande 20 december 2019 Immunicums MERECA-studie utvald för muntlig presentation vid ASCO-SITC Clinical Immuno-Oncology Symposium Immunicum AB (publ) meddelade i dag att abstraktet med...
-
Press Release 20 December 2019 Immunicum AB (publ) Announces Upcoming Oral Presentation on MERECA Trial at the ASCO-SITC Clinical Immuno-Oncology Symposium Immunicum AB (publ; IMMU.ST) announced...